Cargando…
RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
Although the survival rate of patients with cancer have increased due to the use of current chemotherapeutic agents, adverse effects of cancer therapy remain a concern. The reversal of drug resistance, reduction in harmful side effects and accelerated increase in efficiency have often been addressed...
Autores principales: | Tan, Xiao, Zhang, Zhongqiang, Liu, Ping, Yao, Hongliang, Shen, Liangfang, Tong, Jing-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733595/ https://www.ncbi.nlm.nih.gov/pubmed/33311453 http://dx.doi.org/10.1038/s41419-020-03266-3 |
Ejemplares similares
-
Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2023) -
GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF‐κB signaling pathway in colorectal cancer cells
por: Zhang, Zhongqiang, et al.
Publicado: (2018) -
PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer
por: Wang, Huanan, et al.
Publicado: (2015) -
EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
Publicado: (2023) -
Response to LiPuma and DeMarco’s Article on “Hastening Death”
por: Zenz, Julia
Publicado: (2017)